Literature DB >> 8170497

Effects of imidazolines on noradrenaline release in rat isolated kidney.

C Bohmann1, P Schollmeyer, L C Rump.   

Abstract

The aim of the present study was to investigate whether or not activation of imidazoline receptors modulates noradrenaline release in the rat isolated kidney. Kidneys were pre-exposed to 3H-noradrenaline and the renal nerves were stimulated with 6 pulses at 100 Hz. The stimulation induced (S-I) outflow of radioactivity was taken as an index of endogenous noradrenaline release. The imidazoline derivatives clonidine (1-1000 nmol/l) and moxonidine (10-1000 nmol/l) inhibited S-I outflow of radioactivity with an EC50 of 6.8 nmol/l and 62.5 nmol/l and a maximum of 88% and 97%, respectively. The concentration response curves for clonidine and moxonidine were shifted to the right by the selective alpha 2-adrenoceptor antagonist rauwolscine (0.1 mumol/l) in a parallel manner with identical pKB's of 8.52 and 8.46, respectively. Furthermore, the alpha-adrenoceptor agonist (-)-alpha-methylnoradrenaline (0.1-30 nmol/l), which has no affinity for imidazoline binding sites, inhibited S-I outflow of radioactivity with and EC50 of 2.4 nmol/l and a maximum of 94%. Rauwolscine (0.1 mumol/l) again shifted the concentration response curve for this alpha-adrenoceptor agonist to the right with a pKB of 8.40. Moreover, the selective alpha 2-adrenoceptor antagonist 2-[2-(2-methoxy-1,4- benzo-dioxanyl)]imidazoline HCl (RX821002, 0.01 mumol/l) shifted the concentration response curves for clonidine and moxonidine to the right with pKB's of 9.46 and 9.18, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8170497     DOI: 10.1007/bf00169827

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  30 in total

1.  Imidazoline-guanidinium and alpha 2-adrenergic binding sites in basolateral membranes from human kidney.

Authors:  V Lachaud-Pettiti; R A Podevin; Y Chrétien; A Parini
Journal:  Eur J Pharmacol       Date:  1991-01-25       Impact factor: 4.432

2.  Pharmacological characterization of the imidazoline receptor which mediates inhibition of noradrenaline release in the rabbit pulmonary artery.

Authors:  G J Molderings; F Hentrich; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-12       Impact factor: 3.000

Review 3.  [Modulation of renal transmitter release by presynaptic receptors].

Authors:  L C Rump; P Schollmeyer
Journal:  Klin Wochenschr       Date:  1989-09-01

Review 4.  Presynaptic alpha-autoreceptors.

Authors:  K Starke
Journal:  Rev Physiol Biochem Pharmacol       Date:  1987       Impact factor: 5.545

5.  Characterization and visualization of clonidine-sensitive imidazole sites in rat kidney which recognize clonidine-displacing substance.

Authors:  P Ernsberger; G Feinland; M P Meeley; D J Reis
Journal:  Am J Hypertens       Date:  1990-02       Impact factor: 2.689

6.  Involvement of presynaptic imidazoline receptors in the alpha 2-adrenoceptor-independent inhibition of noradrenaline release by imidazoline derivatives.

Authors:  M Göthert; G J Molderings
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-03       Impact factor: 3.000

7.  [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.

Authors:  M C Michel; O E Brodde; B Schnepel; J Behrendt; R Tschada; H J Motulsky; P A Insel
Journal:  Mol Pharmacol       Date:  1989-03       Impact factor: 4.436

8.  Presynaptic autoinhibition of central noradrenaline release in vitro: operational characteristics and effects of drugs acting at alpha-2 adrenoceptors in the presence of uptake inhibition.

Authors:  B Valenta; H Drobny; E A Singer
Journal:  J Pharmacol Exp Ther       Date:  1988-06       Impact factor: 4.030

9.  Pharmacologic differentiation between pre- and postjunctional alpha 2-adrenoceptors by SK&F 104078.

Authors:  R R Ruffolo; A C Sulpizio; A J Nichols; R M DeMarinis; J P Hieble
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-10       Impact factor: 3.000

10.  Modulation of norepinephrine release through alpha 1- and alpha 2-adrenoceptors in rat isolated kidney.

Authors:  L C Rump; H Majewski
Journal:  J Cardiovasc Pharmacol       Date:  1987-04       Impact factor: 3.105

View more
  2 in total

1.  Urinary responses to acute moxonidine are inhibited by natriuretic peptide receptor antagonist.

Authors:  Rouwayda El-Ayoubi; Ahmed Menaouar; Jolanta Gutkowska; Suhayla Mukaddam-Daher
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

2.  Exercise training improves cardiovascular autonomic activity and attenuates renal damage in spontaneously hypertensive rats.

Authors:  Octávio Barbosa Neto; Débora T R S Abate; Moacir Marocolo Júnior; Gustavo R Mota; Fábio L Orsatti; Renata C Rossi e Silva; Marlene A Reis; Valdo J Dias da Silva
Journal:  J Sports Sci Med       Date:  2013-03-01       Impact factor: 2.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.